- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Trex standardizes radiographic, R/F systems
X-ray vendor Trex Medical this month announced a new name for its radiographic and R/F product line that reflects component changes the company has made to its systems. The Danbury, CT-based firm’s Heritage Series consists of standardized versions
X-ray vendor Trex Medical this month announced a new name for its radiographic and R/F product line that reflects component changes the company has made to its systems. The Danbury, CT-based firms Heritage Series consists of standardized versions of the companys existing radiographic and R/F configurations, such as its general radiographic unit, designed for general office use; its orthopedic system, which features a standard table and HFQ 1000 generator; its ER device, which allows users to conduct a full range of anatomical studies; its VIP unit, which includes an integrated tube stand and film receptor; its PMT tomography system, for general purpose and tomography procedures; and its RT-125 device, designed for pediatric applications. The series also includes Trexs 4000M digital chest unit and its 2200I digital radiographic/fluoroscopic device.
With the Heritage Series, Trex consolidates its product line, using the same components across all its divisions. This shift centralizes Trexs manufacturing operations at its Littleton, MA, facility, and produces increased economies of scale. Now-standard components include such items as the HFQ 1000 generator previously used only in Bennetts products, and a radiographic table and overhead tube stand produced by Continental. Devices in the Heritage Series will remain at their existing price points, according to Trex spokesperson John Macko.
Can Portable Dual-Energy X-Ray be a Viable Alternative to CT in the ICU?
September 13th 2024The use of a portable dual-energy X-ray detector in the ICU at one community hospital reportedly facilitated a 37.5 percent decrease in chest CT exams in comparison to the previous three months, according to research presented at the American Society of Emergency Radiology (ASER) meeting in Washington, D.C.
New Meta-Analysis Examines MRI Assessment for Treatment of Esophageal Cancer
September 12th 2024Diffusion-weighted MRI provided pooled sensitivity and specificity rates of 82 percent and 81 percent respectively for gauging patient response to concurrent chemoradiotherapy for esophageal cancer, according to new meta-analysis.
Study for Emerging PET/CT Agent Reveals ‘New Standard’ for Detecting Clear Cell Renal Cell Carcinoma
September 11th 2024Results from a multicenter phase 3 trial showed that the PET/CT imaging agent (89Zr)Zr-girentuximab had an 85.5 percent mean sensitivity rate for the diagnosis of clear cell renal cell carcinoma.
Can Radiomics and Autoencoders Enhance Real-Time Ultrasound Detection of Breast Cancer?
September 10th 2024Developed with breast ultrasound data from nearly 1,200 women, a model with mixed radiomic and autoencoder features had a 90 percent AUC for diagnosing breast cancer, according to new research.
